News Release

News Release

Printer Friendly Version View printer-friendly version
<< Back
Pacira Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that Dave Stack, chief executive officer and chairman of Pacira Pharmaceuticals, Inc. is scheduled to present at the 36th Annual J.P. Morgan Healthcare Conference at 2:00 PM PT (5:00 PM ET) on Tuesday, January 9, 2018 in San Francisco, CA.

A live audio webcast of the Pacira presentation can be accessed by visiting the “Investors & Media” section of the company’s website at investor.pacira.com. A replay of the webcast will be archived on the Pacira website for two weeks following the presentation date.

About Pacira                                                                           

Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty pharmaceutical company dedicated to advancing and improving postsurgical outcomes for acute care practitioners and their patients. The company’s flagship product, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

Company Contact:
Pacira Pharmaceuticals, Inc.
Susan Mesco
(973) 451-4030
Susan.mesco@pacira.com

Primary Logo

Pacira Pharmaceuticals, Inc.